Iteos Therapeutics Stock Price History
| ITOS Stock | USD 8.32 0.19 2.34% |
Below is the normalized historical share price chart for Iteos Therapeutics extending back to July 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iteos Therapeutics stands at 8.32, as last reported on the 23rd of November, with the highest price reaching 8.32 and the lowest price hitting 8.13 during the day.
If you're considering investing in Iteos Stock, it is important to understand the factors that can impact its price. Iteos Therapeutics holds Efficiency (Sharpe) Ratio of -0.24, which attests that the entity had a -0.24% return per unit of risk over the last 3 months. Iteos Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Iteos Therapeutics' Risk Adjusted Performance of (0.17), standard deviation of 4.4, and Market Risk Adjusted Performance of (0.77) to validate the risk estimate we provide.
At this time, Iteos Therapeutics' Stock Based Compensation is comparatively stable compared to the past year. Stock Based Compensation To Revenue is likely to gain to 2.25 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 393.3 M in 2024. . At this time, Iteos Therapeutics' Price To Sales Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.02 in 2024, whereas Price Book Value Ratio is likely to drop 0.65 in 2024. Iteos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 2020 | 200 Day MA 13.0645 | 50 Day MA 9.7929 | Beta 1.39 |
Iteos |
Sharpe Ratio = -0.2432
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ITOS |
Estimated Market Risk
| 4.46 actual daily | 39 61% of assets are more volatile |
Expected Return
| -1.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Iteos Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iteos Therapeutics by adding Iteos Therapeutics to a well-diversified portfolio.
Price Book 0.4702 | Enterprise Value Ebitda 0.4956 | Price Sales 8.4863 | Shares Float 23.9 M | Wall Street Target Price 34.5 |
Iteos Therapeutics Stock Price History Chart
There are several ways to analyze Iteos Stock price data. The simplest method is using a basic Iteos candlestick price chart, which shows Iteos Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 12, 2024 | 16.9 |
| Lowest Price | November 20, 2024 | 7.85 |
Iteos Therapeutics November 23, 2024 Stock Price Synopsis
Various analyses of Iteos Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Iteos Stock. It can be used to describe the percentage change in the price of Iteos Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Iteos Stock.| Iteos Therapeutics Price Rate Of Daily Change | 1.02 | |
| Iteos Therapeutics Price Daily Balance Of Power | 1.00 | |
| Iteos Therapeutics Price Action Indicator | 0.19 |
Iteos Therapeutics November 23, 2024 Stock Price Analysis
Iteos Stock Price History Data
The price series of Iteos Therapeutics for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 has a statistical range of 10.12 with a coefficient of variation of 29.19. Under current investment horizon, the daily prices are spread out with arithmetic mean of 11.32. The median price for the last 90 days is 9.8.| Open | High | Low | Close | Volume | ||
11/23/2024 | 8.13 | 8.32 | 8.13 | 8.32 | ||
| 11/22/2024 | 8.09 | 8.46 | 8.05 | 8.32 | 297,091 | |
| 11/21/2024 | 7.80 | 8.23 | 7.54 | 8.13 | 825,649 | |
| 11/20/2024 | 8.01 | 8.38 | 7.82 | 7.85 | 502,265 | |
| 11/19/2024 | 7.74 | 7.91 | 7.66 | 7.90 | 444,724 | |
| 11/18/2024 | 8.29 | 8.29 | 7.82 | 7.88 | 501,512 | |
| 11/15/2024 | 8.58 | 8.58 | 7.99 | 8.23 | 1,052,727 | |
| 11/14/2024 | 8.74 | 8.79 | 8.05 | 8.46 | 579,162 | |
| 11/13/2024 | 9.28 | 9.40 | 8.81 | 8.83 | 340,720 | |
| 11/12/2024 | 9.63 | 9.63 | 9.09 | 9.19 | 370,527 | |
| 11/11/2024 | 9.29 | 9.71 | 9.27 | 9.38 | 333,985 | |
| 11/08/2024 | 9.09 | 9.38 | 8.92 | 9.27 | 372,778 | |
| 11/07/2024 | 9.37 | 9.60 | 9.00 | 9.18 | 417,146 | |
| 11/06/2024 | 9.22 | 9.64 | 9.08 | 9.40 | 792,205 | |
| 11/05/2024 | 8.97 | 9.27 | 8.70 | 9.22 | 578,897 | |
| 11/04/2024 | 8.76 | 9.11 | 8.57 | 8.97 | 629,995 | |
| 11/01/2024 | 8.47 | 8.93 | 8.43 | 8.81 | 829,934 | |
| 10/31/2024 | 8.54 | 8.84 | 8.41 | 8.45 | 687,652 | |
| 10/30/2024 | 8.50 | 8.97 | 8.48 | 8.59 | 368,706 | |
| 10/29/2024 | 8.87 | 9.14 | 8.55 | 8.58 | 529,772 | |
| 10/28/2024 | 8.77 | 8.99 | 8.70 | 8.93 | 380,827 | |
| 10/25/2024 | 8.59 | 9.15 | 8.59 | 8.72 | 390,207 | |
| 10/24/2024 | 8.90 | 8.99 | 8.55 | 8.60 | 880,555 | |
| 10/23/2024 | 8.91 | 9.00 | 8.63 | 8.85 | 814,991 | |
| 10/22/2024 | 9.04 | 9.15 | 8.88 | 8.99 | 903,742 | |
| 10/21/2024 | 9.35 | 9.36 | 8.91 | 9.10 | 972,209 | |
| 10/18/2024 | 9.66 | 9.80 | 8.99 | 9.43 | 1,726,154 | |
| 10/17/2024 | 9.50 | 9.69 | 9.40 | 9.61 | 658,736 | |
| 10/16/2024 | 9.46 | 9.62 | 9.32 | 9.55 | 440,145 | |
| 10/15/2024 | 9.76 | 9.76 | 9.39 | 9.42 | 481,571 | |
| 10/14/2024 | 9.88 | 10.10 | 9.57 | 9.73 | 722,804 | |
| 10/11/2024 | 9.11 | 10.21 | 9.11 | 9.95 | 800,554 | |
| 10/10/2024 | 9.04 | 9.09 | 8.74 | 9.07 | 568,626 | |
| 10/09/2024 | 9.41 | 9.41 | 9.10 | 9.16 | 455,351 | |
| 10/08/2024 | 9.67 | 9.79 | 9.42 | 9.43 | 462,043 | |
| 10/07/2024 | 9.96 | 10.22 | 9.65 | 9.80 | 370,014 | |
| 10/04/2024 | 9.61 | 10.07 | 9.59 | 10.02 | 445,157 | |
| 10/03/2024 | 9.78 | 9.90 | 9.62 | 9.69 | 394,654 | |
| 10/02/2024 | 9.83 | 10.11 | 9.75 | 9.82 | 703,477 | |
| 10/01/2024 | 10.16 | 10.17 | 9.77 | 10.00 | 757,241 | |
| 09/30/2024 | 10.50 | 10.93 | 9.93 | 10.21 | 698,648 | |
| 09/27/2024 | 10.19 | 10.59 | 10.09 | 10.50 | 353,021 | |
| 09/26/2024 | 10.10 | 10.42 | 10.03 | 10.16 | 617,117 | |
| 09/25/2024 | 10.15 | 10.50 | 10.01 | 10.09 | 551,578 | |
| 09/24/2024 | 10.52 | 10.59 | 9.96 | 10.13 | 956,546 | |
| 09/23/2024 | 11.37 | 11.37 | 10.57 | 10.60 | 509,357 | |
| 09/20/2024 | 11.17 | 11.47 | 11.02 | 11.26 | 888,647 | |
| 09/19/2024 | 11.52 | 11.74 | 11.20 | 11.22 | 832,858 | |
| 09/18/2024 | 12.12 | 12.26 | 11.50 | 11.59 | 962,768 | |
| 09/17/2024 | 12.14 | 12.30 | 11.40 | 12.12 | 1,196,628 | |
| 09/16/2024 | 14.31 | 14.50 | 11.22 | 12.10 | 5,785,695 | |
| 09/13/2024 | 16.98 | 17.52 | 16.69 | 16.70 | 862,259 | |
| 09/12/2024 | 16.00 | 17.63 | 15.63 | 16.90 | 1,177,543 | |
| 09/11/2024 | 15.96 | 16.13 | 15.70 | 15.99 | 775,490 | |
| 09/10/2024 | 15.63 | 16.05 | 15.39 | 15.99 | 470,465 | |
| 09/09/2024 | 15.00 | 16.09 | 14.75 | 15.56 | 794,790 | |
| 09/06/2024 | 15.53 | 16.21 | 14.74 | 14.80 | 1,049,244 | |
| 09/05/2024 | 16.34 | 16.41 | 15.45 | 15.50 | 507,427 | |
| 09/04/2024 | 16.55 | 16.62 | 16.18 | 16.25 | 209,641 | |
| 09/03/2024 | 16.74 | 17.43 | 16.51 | 16.66 | 321,308 | |
| 08/30/2024 | 16.99 | 17.36 | 16.65 | 16.85 | 410,491 |
About Iteos Therapeutics Stock history
Iteos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iteos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iteos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iteos Therapeutics stock prices may prove useful in developing a viable investing in Iteos Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 35.8 M | 34.6 M | |
| Net Income Applicable To Common Shares | 111.1 M | 116.7 M |
Iteos Therapeutics Quarterly Net Working Capital |
|
Iteos Therapeutics Stock Technical Analysis
Iteos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Iteos Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iteos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Iteos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iteos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.19) | |||
| Total Risk Alpha | (1.63) | |||
| Treynor Ratio | (0.78) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Iteos Stock Analysis
When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.